![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HEALTH-RELATED QUALITY OF LIFE (HRQOL) BEFORE AND AFTER TREATMENT OF GENOTYPE 1 (GT1) INFECTION WITH ELBASVIR/GRAZOPREVIR (EBR/GZR): RESULTS FROM THE GERMAN HEPATITIS C REGISTRY (DHC-R)
|
|
|
EASL 2020 Aug 27-29
Reported by Jules Levin
Dietrich Huppe1, Albrecht Stoehr2, Hartwig Klinker3, Renate Heyne4, Christine John5, Karl-Georg Simon6, Manfred Bilzer7, Veronika Guenther8, Markus Becker-Camps8, Vanessa Witte8, Markus Cornberg9
1Gastroenterologische Gemeinschaftspraxis, Herne; 2Institute for Interdisciplinary Medicine, Hamburg; 3University Hospital Wurzburg, Wurzburg; 4Leberzentrum am Checkpoint, Berlin; 5Private Practice of Internal Medicine, Berlin; 6MVZ Dres. Eisenbach, Simon, Schwarz GbR, Leverkusen; 7Bilzer Consulting, Munchen; 8MSD Sharp & Dohme GmbH, Haar; 9Hannover Medical School, Hannover
![0921201](../images/092120/092120-8/0921201.gif)
![0921202](../images/092120/092120-8/0921202.gif)
![0921203](../images/092120/092120-8/0921203.gif)
![0921204](../images/092120/092120-8/0921204.gif)
![0921205](../images/092120/092120-8/0921205.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|